Volume 109, Issue 2, Pages 120-127 (February 2010)

5 of 11

ABSTRACT

ABSTRACT + REFS

FULL-TEXT PDF (224 KB)

High Prevalence of Mutations in Quinolone-resistance-determining Regions and mtrR Loci in Polyclonal Neisseria gonorrhoeae Isolates at a Tertiary Hospital in Southern Taiwan

Received 14 January 2009; received in revised form 6 March 2009; accepted 8 June 2009.

Background/Purpose

The emergence of multidrug-resistant Neisseria gonorrhoeae is a great challenge in controlling gonorrhea. This study was conducted to survey the prevalence of molecular mechanisms of antimicrobial resistance among 45 clinical isolates of N. gonorrhoeae collected at a university hospital in Southern Taiwan during 1999-2004.

Methods

Mutations in mtrR loci and quinolone-resistance-determining regions (QRDRs) were examined by gene sequencing. Polymerase chain reactions with specific primers were performed to detect ermA, ermB, ermC, and ermF. Serogroups and serovars were determined by commercial kits.

Results

The percentage of multidrug resistance, that is, resistance to penicillin, tetracycline, erythromycin, and ciprofloxacin, among the 45 isolates was 40%. Ceftriaxone and spectinomycin were active against all isolates in vitro. The frequency of mutations in the QRDR and mtrR promoter was 82.2% and 93.3%, respectively. Eighty-two percent of the isolates carried mutations both in the QRDR and mtrR loci. Of nine mutation profiles with QRDR mutations (n =37), gyrA-Ser91Phe/gyrA-Asp95Gly/parC-Ser87Arg was the most common type (56.8%). Acquired genes for rRNA methylase were detected in 11 isolates (10 ermB and 1 ermA). Twenty-seven serovars were identified and all belonged to serogroup B, which suggested that multiple clones of N. gonorrhoeae were circulating in the community in the Tainan area.

Conclusion

The high prevalence of multidrug resistance caused by varied resistance mechanisms in N. gonorrhoeae limits the drug choice. Ongoing surveillance of antimicrobial resistance and discovery of new effective antibiotic therapy are warranted in endemic areas.

Key Words: antibiotic resistance , azithromycin , ciprofloxacin , fluoroquinolones , Neisseria gonorrhoeae

No full text is available. To read the body of this article, please view the PDF online.

Article Outline

• Abstract

• References

• Copyright

References

1. 1 Tapsall JW . Antibiotic resistance in Neisseria gonorrhoeae . Clin Infect Dis . 2005;41(Suppl 4):S263–S268 . CrossRef

2. 2 Workowski KA , Berman SM , Douglas JM . Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies . Ann Intern Med . 2008;148:606–613 .

3. 3 Workowski KA , Berman SM . Sexually transmitted diseases treatment guidelines, 2006 . MMWR Recomm Rep . 2006;55:1–94 .

4. 4 Su X , Lind I . Molecular basis of high-level ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Denmark from 1995 to 1998 . Antimicrob Agents Chemother . 2001;45:117–123 . MEDLINE | CrossRef

5. 5 Shultz TR , Tapsall JW , White PA . Correlation of in vitro susceptibilities to newer quinolones of naturally occurring quinolone-resistant Neisseria gonorrhoeae strains with changes in GyrA and ParC . Antimicrob Agents Chemother . 2001;45:734–738 . MEDLINE | CrossRef

6. 6 Tanaka M , Nakayama H , Haraoka M , et al. Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998 . J Clin Microbiol . 2000;38:521–525 . MEDLINE

7. 7 Shortridge VD , Flamm RK , Ramer N , et al. Novel mechanism of macrolide resistance in Streptococcus pneumoniae . Diagn Microbiol Infect Dis . 1996;26:73–78 . Abstract | Full-Text PDF (694 KB) | CrossRef

8. 8 Roberts MC , Chung WO , Roe D , et al. Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes . Antimicrob Agents Chemother . 1999;43:1367–1372 . MEDLINE

9. 9 Hagman KE , Pan W , Spratt BG , et al. Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system . Microbiology . 1995;141:611–622 .

10. 10 Morse SA , Lysko PG , McFarland L , et al. Gonococcal strains from homosexual men have outer membranes with reduced permeability to hydrophobic molecules . Infect Immun . 1982;37:432–438 . MEDLINE

11. 11 Lucas CE , Balthazar JT , Hagman KE , et al. The MtrR re-pressor binds the DNA sequence between the mtrR and mtrC genes of Neisseria gonorrhoeae . J Bacteriol . 1997;179:4123–4128 . MEDLINE

12. 12 Zarantonelli L , Borthagaray G , Lee EH , et al. Decreased susceptibility to azithromycin and erythromycin mediated by a novel mtr(R) promoter mutation in Neisseria gonorrhoeae . J Antimicrob Chemother . 2001;47:651–654 . MEDLINE | CrossRef

13. 13 Zarantonelli L , Borthagaray G , Lee EH , et al. Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations . Antimicrob Agents Chemother . 1999;43:2468–2472 . MEDLINE

14. 14 Johnson SR , Sandul AL , Parekh M , et al. Mutations causing in vitro resistance to azithromycin in Neisseria gonorrhoeae . Int J Antimicrob Agents . 2003;21:414–419 . Abstract | Full Text | Full-Text PDF (275 KB) | CrossRef

15. 15 Cousin SL , Whittington WL , Roberts MC . Acquired macrolide resistance genes and the 1 bp deletion in the mtrR promoter in Neisseria gonorrhoeae . J Antimicrob Chemother . 2003;51:131–133 . MEDLINE | CrossRef

16. 16 Dewi BE , Akira S , Hayashi H , et al. High occurrence of simultaneous mutations in target enzymes and MtrRCDE efflux system in quinolone-resistant Neisseria gonorrhoeae . Sex Transm Dis . 2004;31:353–359 . MEDLINE | CrossRef

17. 17 Chu ML , Ho LJ , Lin HC , et al. Epidemiology of penicillin-resistant Neisseria gonorrhoeae isolated in Taiwan, 1960-1990 . Clin Infect Dis . 1992;14:450–457 . MEDLINE

18. 18 Hsueh PR , Tseng SP , Teng LJ , et al. High prevalence of ciprofloxacin-resistant Neisseria gonorrhoeae in Northern Taiwan . Clin Infect Dis . 2005;40:188–192 . CrossRef

19. 19 Center for Disease Control and Prevention, Taiwan . Communicable Diseases and Prevention: Gonorrhea [In Chinese] . Available at: http://www.cdc.gov.tw/sp.asp?xdurl=disease/disease_content.asp&id=794&mp=1&ctnode=1498#2 [Date accessed: March 1, 2009] .

20. 20 Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th informational supplement, Wayne PA, 2006:M100-S16.

21. 21 Center for Disease Control and Prevention . Neisseria gonorrhoeae Reference Strains for Antimicrobial Susceptibility Testing . Available at: http://www.cdc.gov/std/Gonorrhea/arg/B88text6132003.pdf [Date accessed: March 1, 2009] .

22. 22 National Committee for Clinical Laboratory Standards . Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved standard M7-A3 . Villanova, PA: NCCLS; 1993; .

23. 23 Belland RJ , Morrison SG , Ison C , et al. Neisseria gonorrhoeae acquires mutations in analogous regions of gyrA and parC in fluoroquinolone-resistant isolates . Mol Microbiol . 1994;14:371–380 . CrossRef

24. 24 Wang SA , Harvey AB , Conner SM , et al. Antimicrobial resistance for Neisseria gonorrhoeae in the United States, 1988 to 2003: the spread of fluoroquinolone resistance . Ann Intern Med . 2007;147:81–88 .

25. 25 Bala M , Ray K , Gupta SM , et al. Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains . J Antimicrob Chemother . 2007;60:582–586 . CrossRef

26. 26 Wong WW , Huang CT , Li LH , et al. Molecular epidemiology of gonorrhea identified clonal clusters with distinct susceptibilities associated with specific high-risk groups . J Clin Microbiol . 2008;46:3931–3934 . CrossRef

27. 27 Steingrimsson O , Olafsson JH , Thorarinsson H , et al. Azithromycin in the treatment of sexually transmitted disease . J Antimicrob Chemother . 1990;25(Suppl A):109–114 .

28. 28 Dan M , Poch F , Amitai Z , et al. Pharyngeal gonorrhea in female sex workers: response to a single 2-g dose of azithromycin . Sex Transm Dis . 2006;33:512–515 . MEDLINE | CrossRef

29. 29 Young H , Moyes A , McMillan A . Azithromycin and erythromycin resistant Neisseria gonorrhoeae following treatment with azithromycin . Int J STD AIDS . 1997;8:299–302 . MEDLINE | CrossRef

30. 30 Tapsall JW , Shultz TR , Limnios EA , et al. Failure of azithromycin therapy in gonorrhea and discorrelation with laboratory test parameters . Sex Transm Dis . 1998;25:505–508 . MEDLINE | CrossRef

31. 31 Martin DH , Mroczkowski TF , Dalu ZA , et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis . N Engl J Med . 1992;327:921–925 . MEDLINE | CrossRef

32. 32 Shafer WM , Balthazar JT , Hagman KE , et al. Missense mutations that alter the DNA-binding domain of the MtrR protein occur frequently in rectal isolates of Neisseria gonorrhoeae that are resistant to faecal lipids . Microbiology . 1995;141:907–911 .

33. 33 Xia M , Whittington WL , Shafer WM , et al. Gonorrhea among men who have sex with men: outbreak caused by a single genotype of erythromycin-resistant Neisseria gonorrhoeae with a single-base pair deletion in the mtrR promoter region . J Infect Dis . 2000;181:2080–2082 . MEDLINE | CrossRef

34. 34 Luna VA , Cousin S , Whittington WL , et al. Identification of the conjugative mef gene in clinical Acinetobacter junii and Neisseria gonorrhoeae isolates . Antimicrob Agents Chemother . 2000;44:2503–2506 . MEDLINE | CrossRef

35. 35 Ng LK , Martin I , Liu G , et al. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae . Antimicrob Agents Chemother . 2002;46:3020–3025 . MEDLINE | CrossRef

36. 36 Camarena JJ , Nogueira JM , Dasi MA , et al. DNA amplification fingerprinting for subtyping Neisseria gonorrhoeae strains . Sex Transm Dis . 1995;22:128–136 . MEDLINE | CrossRef

37. 37 Aydin D , Koksalan K , Komec S , et al. Auxo-, sero-, and opa-typing of Neisseria gonorrhoeae strains isolated in Istanbul, Turkey . Sex Transm Dis . 2004;31:628–630 . MEDLINE

a Department of Medicine, National Cheng Kung University Medical College, Tainan, Taiwan

b Department of Nursing, National Cheng Kung University Medical College, Tainan, Taiwan

c Department of Public Health, National Cheng Kung University Medical College, Tainan, Taiwan

d Institute of Clinical Medicine, National Cheng Kung University Medical College, Tainan, Taiwan

e Center for Infection Control, National Cheng Kung University Hospital, Tainan, Taiwan

f Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan

g Department of Pathology, National Cheng Kung University Hospital, Tainan, Taiwan

h Department of Emergency Medicine, National Cheng Kung University Hospital, Tainan, Taiwan

i Division of Clinical Research, National Health Research Institutes, Tainan, Taiwan

j Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Correspondence to: Dr Wen-Chien Ko, Division of Infectious Diseases, Department of Internal Medicine, National Cheng Kung University Hospital, 138 Sheng Li Road, Tainan 704, Taiwan

PII: S0929-6646(10)60032-0

doi:10.1016/S0929-6646(10)60032-0

5 of 11